Seoul, South Korea

Myeong Jun Choi

This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Axceso Biopharma Co., Ltd., Phytos Co., Ltd. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myeong Jun Choi. Retrieved from https://idiyas.com/inventor/myeong-jun-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0


 

Average Co-Inventor Count = 1.4

ph-index = 1


Location History:

  • Gyunggido, KR (2014)
  • Seoul, KR (2017 - 2021)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Myeong Jun Choi: Innovator in Neuropharmaceuticals

Introduction

Myeong Jun Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of neuropharmaceuticals, particularly in the treatment of neurodegenerative diseases such as Parkinson's disease and dementia. With a total of 4 patents to his name, Choi's work is paving the way for innovative therapeutic solutions.

Latest Patents

Choi's latest patents include a composition comprising O-cyclic phytosphingosine-1-phosphate aimed at preventing or treating Parkinson's disease. This pharmaceutical composition is designed to prevent the death of SH-SY5Y nerve cells, which are crucial dopaminergic nerve cells. It also enhances the expression of tyrosine hydroxylase, an enzyme essential for dopamine formation. Consequently, this composition holds promise for effectively preventing or treating Parkinson's disease.

Another notable patent involves the use of phytosphingosine-1-phosphate and its derivatives as immune enhancers or pharmaceutical compositions for treating dementia. This invention highlights the potential of these substances to enhance the Th2 immune response while inhibiting the Th1 immune response. Additionally, it demonstrates protective effects on neurons, making it a valuable candidate for developing a dementia vaccine.

Career Highlights

Myeong Jun Choi has worked with several companies, including Axceso Biopharma Co., Ltd. and Phytos Co., Ltd. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical compositions.

Collaborations

Choi has collaborated with notable colleagues such as Won Kyo Han and Young Jun Park. These partnerships have further enriched his research and development efforts in the field of neuropharmaceuticals.

Conclusion

Myeong Jun Choi is a distinguished inventor whose work in neuropharmaceuticals is making a significant impact on the treatment of Parkinson's disease and dementia. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…